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Abstract 
We identify a novel endothelial membrane behaviour in transgenic zebrafish. Cerebral 
blood vessels extrude large transient spherical structures that persist for an average 
of 23 minutes before regressing into the parent vessel. We term these structures 
³kugeln´, after the German for sphere. 
Kugeln are only observed arising from the cerebral vessels and are present as late as 
28 days post fertilisation. Kugeln do not communicate with the vessel lumen and can 
form in the absence of blood flow. They contain little or no cytoplasm but the majority 
are highly positive for nitric oxide reactivity. Kugeln do not interact with brain lymphatic 
endothelial cells (BLECs) and can form in their absence, nor do they perform a 
scavenging role or interact with macrophages. Inhibition of actin polymerisation, 
myosin II, or Notch signalling reduce kugel formation, while inhibition of VEGF or Wnt 
dysregulation (either inhibition or activation) increase kugel formation. 
Kugeln represent a novel Notch-dependent NO-containing endothelial organelle 
restricted to the cerebral vessels, of currently unknown function.  
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Introduction 
Formation of mature blood vessels requires a wide range of endothelial behaviours. 
These include proliferation, migration, anastomosis, lumen formation, remodelling, 
and pruning, alongside recruitment of non-endothelial cell types such as pericytes and 
vascular smooth muscle cells 1±4. Many of these processes can be studied in vitro, but 
in vivo models of vascular development allow observation of endothelial behaviour 
within a multicellular and complex physiological environment. 
Because visualising real-time embryonic vascular development in mammals is 
technically challenging, the zebrafish has become a widely applied model of vertebrate 
vascular development. Their translucency enables detailed observation of cellular 
behaviour without invasive instrumentation in vivo 5,6. An increasing array of transgenic 
reporter lines that drive fluorescent gene expression in vascular cells is available. 
Coupling these with state-of-the-art imaging techniques, such as light sheet 
fluorescence microscopy (LSFM), enables detailed cellular and subcellular imaging 
for hours or even days during embryonic development 7,8. This ability to observe 
vascular development in more detail and for longer durations provides new insights 
into blood vessel formation. 
Endothelial and other cells are known to form a variety of membranous vesicles 9. 
These include apoptotic bodies (1-ȝP diameter), microvesicles (0.15-ȝP diameter) 
and exosomes (40-150nm diameter) 10. There is increasing evidence that such 
vesicles play important roles in intracellular signalling 11, and in vascular diseases such 
as atherosclerosis 12. Understanding the roles of such vesicles is therefore of both 
biological and clinical significance. 
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Here we report a novel type of endothelial cell vesicle formation with characteristics 
that are entirely distinct from any previously described membrane behaviour. We show 
that endothelial cells (ECs) of the zebrafish cerebral vasculature (but not other 
vessels) extrude spherical structures far larger than any previously described 
microvesicle 10, and unlike previously described vesicles never detach from the parent 
endothelial cell. 
Due to their unknown nature and function we termed these structures kugeln (German 
for spheres) and we here characterise their morphology, dynamics, and sites of 
occurrence. We find that kugeln are membranous protrusions that do not contain either 
nuclei or cytoplasm. Although very different in size and behaviour to other vesicular 
structures, inhibition of the cytoskeletal components filamentous actin (F-actin) 
formation or Myosin II reduced kugeln formation, as previously shown for cellular 
blebs13. Kugeln do not interact with brain lymphatic endothelial cells (BLECs) 14,15 or 
macrophages, nor do they serve as scavengers. Kugeln formation is not influenced by 
either increased membrane rigidity, nor osmotic pressure, which are known to impact 
platelet ballooning and cellular blebbing 13,16. 
Kugel formation can proceed in the absence of blood flow. Furthermore we show that 
central orchestrators of vascular development such as Notch, VEGF and Wnt 
signalling 17±20 all influence kugel formation.  
Together, our data suggest that kugeln represent a previously undescribed EC 
membrane behaviour restricted to the cerebral vessels. Their function remains 
unknown but their existence emphasises that our understanding of the intricate 
processes during vascular development is far from complete. 
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Results 
Endothelial cells of zebrafish cerebral vessels frequently develop large 
extruding spherical structures 
We initially observed that the endothelial cells of the cerebral vessels of transgenic 
Tg(kdrl:HRAS-mCherry)s916 zebrafish expressing an endothelial membrane-tagged 
reporter protein21  displayed rounded protrusions (Figure 1A). Although the 
appearance of these on single z-slices was similar to cross-sections of lumenized 
vessels, three-dimensional reconstruction showed them to be spherical abluminal 
protrusions (EV Movie 1). Due to their shape and unknown nature we termed these 
structures kugeln, after the German for sphere (singular kugel). The mean diameter of 
kugeln was 10.1 ± 0.5µm (s.e.m.) at 3dpf (Figure 1B) exceeding the size of previously 
described membrane derived vesicles 10. 
Mean number of kugeln per embryo was 5.55 ± 1.12 (s.e.m.) at 3dpf, and was not 
significantly different between 3-5dpf (p 0.8571; Figure 1C). We were able to observe 
kugeln in 28dpf animals (Figure 1D), confirming that kugeln are present beyond 
embryonic stages. 
To exclude the possibility that kugeln arise as a strain-specific feature of the transgenic 
line Tg(kdrl:HRAS-mCherry)s916 we imaged a different transgenic, Tg(fli1aep:CAAX-
eGFP) 22 which utilizes the pan-endothelial promotor fli1a 8 and prenylation to target 
eGFP to the endothelial membrane. Again, kugeln were observed to arise from 
cerebral vessels (Figure 1E). We furthermore induced transient expression of the 
plasmid pTol2-fli1a:myr-mCherry 23,24, which uses the same fli1a promotor, and utilizes 
myristoylation to label the EC membrane. This was performed in Tg(gata1:dsRed) 
transgenics to enable vessel localization. Again, kugeln were observed in these 
embryos (Figure 1F), demonstrating that kugel formation was independent of the 
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transgenic construct used, the promotor driving its expression, and the method of 
membrane tagging. Therefore, we concluded that kugeln represent a physiological 
behaviour of the EC membrane of the cranial vasculature. 
We mapped the location of kugeln on parent vessels to determine their distribution. 
>90% of kugeln arose from the central vessels of the cerebral vasculature (Figure 1G) 
and none from the trunk vasculature (aorta, intersegmental vessels, dorsal longitudinal 
anastomotic vessel or caudal vein) at the examined time-points. The specific vessels 
giving rise to kugeln are shown in Figure 1H.  
Although individual kugeln were often unilateral (present left-side but not right-sided 
vessels, or vice versa) overall left/right distribution was not significantly different 
(Figure 1H). 
 
Kugeln are highly dynamic transient structures 
We next observed kugel behaviour over time. Time-lapse imaging revealed kugeln 
were both transient and highly dynamic (Figure 2A). Although we expected kugeln to 
form new vessels, interact with other ECs to anastomose, or detach from parent 
vessels, kugeln always either regressed back into the parent vessel or persisted to the 
end of imaging without separation or anastomosis. 
Quantification of kugel lifespan showed that while some regressed after minutes, 
others persisted for hours (Figure 2B).  Further examination showed that kugeln 
displayed dynamic alteration in shape and size, including shape changes, 
enlargement and retraction (Figure 2C; EV Movie 2). This dynamic behaviour was 
observed not only in Tg(kdrl:HRAS-mCherry)s916 animals but also in Tg(fli1ep:CAAX-
eGFP) (Figure EV1A,B) and Tg(fli1a:myr-mCherry), Tg(gata1:dsRed) (Figure EV1C). 
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Although some animals displayed no kugeln when observed at a single timepoint 
(Figure 1C), timelapse imaging showed kugeln could develop at subsequent 
timepoints (Figure 2D). 
When we studied kugel shape change over time this revealed that some kugeln 
displayed oscillatory diameter changes with a periodicity of minutes (Figure 2E). No 
such changes were observed in parent vessels, suggesting alterations of kugel size 
or shape are not directly related to blood pressure or flow but related to active 
membrane remodelling. 
 
Kugeln are membranous structures whose formation is dependent on the 
cytoskeleton 
We next investigated the composition and biogenesis of kugeln. Examining double-
transgenic embryos Tg(kdr:nls-eGFP)zf109, Tg(kdrl:HRAS-mCherry)s916  that labelled 
endothelial nuclei and membrane, we never observed kugeln to contain a nucleus, 
nuclear defragmentation or observed nuclear mitosis nearby kugeln (Figure 3A). This 
suggests kugeln do not represent an atypical form of cell proliferation, apoptosis, or 
angiogenic sprouting.  
Analysing the double-transgenic line Tg(fli1a:LifeAct-mClover)sh467, Tg(kdrl:HRAS-
mCherry)s916 labelling filamentous actin (F-actin) and EC membrane, we observed that 
F-actin co-localized with kugeln, especially at the kugel ³QHFN´ (Figure 3B). Time-
lapse microscopy revealed this enrichment of F-actin at the kugel neck to be highly 
dynamic (EV Movie 3). 
To further examine the contents of kugeln, we imaged the double-transgenic 
Tg(fli1a:eGFP)y1, Tg(kdrl:HRAS-mCherry)s916 that labels the EC cytosol and 
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membrane. We were unable to visualize cytosolic GFP within kugeln indicating they 
contain little if any cytoplasm (Figure 3C). 
To further characterise the content inside and tissue surrounding kugeln, we examined 
the triple-transgenic Tg(gata1:dsRed), Tg(nbt:GCaMP3), Tg(kdrl:HRAS-mCherry)s916, 
that labels red blood cells (RBCs), developing neurons and EC membrane. RBCs were 
never observed within kugeln. Examination of neurons showed an exclusion of neural 
tissue (Figure 3D), confirming kugeln displace rather than include neural tissue. 
 
Kugel formation is reduced by F-actin or Myosin II inhibition 
Since F-actin was enriched at kugel necks, we examined whether this was necessary 
for growth and/or maintenance of kugeln. Thus, actin polymerization was inhibited by 
application of Latrunculin B. This led to a significant increase of number of kugeln per 
embryo (Figure 3E; p 0.0041), but a significant decrease of kugel diameter (Figure 
3F; p 0.0164). 
The role of Myosin II was investigated by chemical inhibition by Blebbistatin treatment. 
This significantly reduced the number of kugeln per embryo (Figure 3G; p<0.0001) 
but did not affect kugeln diameter (Figure 3H; p 0.3731). 
The finding that F-actin inhibition increased, while Myosin II inhibition decreased, kugel 
number is consistent with the effect of these manipulations on cellular blebs13, 
suggesting some shared mechanisms of kugel and bleb biogenesis. 
 
Blood flow is not required for kugel formation, maintenance, retraction, or 
oscillation 
To study the impact of blood flow and blood pressure we performed exsanguination 
by cardiac puncture to reduce blood pressure and flow to zero. Imaging the same 
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animals pre- and post- exsanguination showed no effect on kugel size or shape 
(Figure 4A,B) suggesting neither flow nor pressure are needed to maintain kugeln 
once they have formed. To confirm this, cardiac contraction was temporarily stopped 
by high-dose Tricaine application and time-lapses acquired. Despite absent blood 
flow, kugeln still developed, changed shape and retracted (Figure 4C and Figure 4D) 
as seen under normal blood flow conditions. 
We next performed microangiography with fluorescent dextran to investigate whether 
kugeln were perfused by blood or communicated with the lumen of the parent vessel. 
No entry of dextran into kugeln was observed (Figure 4E), suggesting no such 
communication existed, at least after kugeln were formed. 
Lastly, we prevented development of heart contraction by morpholino (MO) 
knockdown of cardiac troponin 2a (tnnt2a) 25±27. This induced a significant decrease 
in number of kugeln per embryo (Figure 4F; p<0.0001). 
Together, these data suggest that blood flow is not the driving mechanism of kugel 
formation, retraction, or oscillation; but that vessels that have never experienced flow 
do not form kugeln. 
 
Altered membrane permeability or osmotic pressure do not affect kugel 
formation or diameter 
Since DMSO increases membrane permeability 28 we examined whether this had an 
impact on kugel formation. We incubated embryos for 24h in 2.5% DMSO and found 
no significant difference in kugel number (Figure EV 2A; p 0.1596) or diameter 
(Figure EV2B; p 0.3665). 
As osmotic pressure increases cellular bleb formation and platelet ballooning 13,16, we 
examined whether kugeln were altered by increased osmotic pressure. Embryos were 
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incubated for 24h in a 40mM glucose solution. No significant difference was found in 
kugel number (Figure EV2C; p 0.7371) or diameter (Figure EV2D; p 0.7060). 
 
Lymphatic cells did not interact with kugeln 
Next we investigated the relationship between kugeln and the meningeal population 
of lymphatic cells, brain lymphatic endothelial cells (BLECs) 14. We first investigated 
whether BLECs interacted physically with kugeln in the double-transgenic 
Tg(kdrl:HRAS-mCherry)s916 , Tg(fli1a:Lifeact-mClover)sh467, which allowed us to 
visualize BLECs as mClover-positive but mCherry-negative structures (Figure 5A-C). 
BLECs were observed to be at a different anatomical depth than kugeln (Figure 5D) 
and no direct interaction between BLECs and kugeln was ever observed (n=21, 4dpf 
embryos; 3 experimental repeats). 
To examine whether lymphatics are required for kugeln formation, BLEC formation 
was inhibited by MO knockdown of ccbe1 (Figure 5E) 21. This had no effect on either 
number of kugeln per embryo (Figure 5F), nor kugel diameter (Figure 5G). 
These findings were confirmed by imaging the double-transgenic Tg(kdrl:HRAS-
mCherry)s916 , Tg(flt4BAC:mCitrine)hu7135, which more specifically labels BLECs (Figure 
EV3A). Again, ccbe1 MO knockdown had no effect on kugel number (Figure 
EV3B&C; p 0.1472) or diameter (Figure EV3D; p 0.0962). 
Next, we examined whether kugeln serve an uptake function, similar to BLECs14. We 
studied whether IgG-conjugated Alexa Fluor 674, injected into the tectum, would be 
taken up by kugeln. While BLECs readily took up the IgG-conjugated Alexa, this was 
was not observed in kugeln (Figure 5H; 140 kugeln from 17 4dpf embryos; Figure 
EV3E 52 kugeln from five 5dpf embryos). 
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Macrophages do not interact with kugeln 
Since macrophages interact with vessels undergoing anastomosis 29, we imaged the 
triple transgenic line Tg(fms:GAL4.VP16)i186, Tg(UAS-E1b:nfsB.mCherry)il149, 
Tg(kdrl:HRAS-mCherry)s916, which labels both macrophages and endothelial cells with 
mCherry (Figure 6A). To distinguish the anatomical depth of kugeln and 
macrophages, depth-coding was performed; also, macrophages could be identified by 
cell shape and movement between frames of time-lapses (Figure 6B). We never 
observed direct interaction of macrophages with kugeln (Figure 6C; EV Movie 4; n=21 
kugeln in eight 3dpf embryo), suggesting that kugeln do not directly respond to local 
inflammation, and/or recruitment of macrophages 29. 
 
Number of kugeln is increased by VEGF inhibition and whilst kugeln contain 
NO, they do not require NO synthase for their formation 
Due to the essential role of VEGF in angiogenesis we examined the effect of VEGF 
signalling inhibition on kugel formation 17,30. The VEGF inhibitor AV951 significantly 
increased the number of kugeln per embryo (Figure 7A; p<0.0001), without affecting 
kugel diameter (Figures 7B; p 0.7890). Since nitric oxide (NO) is induced by VEGF 31 
we incubated embryos with the vital dye DAF-FM, which fluoresces green in contact 
with NO 32,33. We found 57.76% of kugeln (118 of 205 kugeln; 22 embryos) were 
fluorescent, indicating high levels of NO reactivity (Figure 7C). To identify at which 
point kugeln begin to contain NO we performed time-lapse microscopy of kugel 
formation after DAF-FM staining and found NO-reactivity was detectible at the start of 
kugel formation (Figure 7D). Because DAF-FM can fluoresce in acidic environments 
even in the absence of NO 34, we performed LysoTracker staining, which visualises 
acidic cell compartments 35,36. Only 17.08% of kugeln were positive for LysoTracker 
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(Figure 7E; 62 of 363 kugeln; 22 embryos) suggesting that kugeln do indeed contain 
NO. 
We examined whether nitric oxide synthase (NOS) was required for kugel formation 
by application of the NOS inhibitor L-NAME 31,37. Neither kugel number (Figure 7F; p 
0.4870) nor diameter were significantly altered by L-NAME treatment (Figure 7G; p 
0.4161).  
 
Notch signalling is required for kugel formation 
Having found that VEGF signalling negatively regulates kugel formation, we studied 
its counter-part Notch 19,38,39. Pharmacological inhibition of Notch signalling by DAPT 
significantly reduced kugel number (Figure 8A; p<0.0001), while not significantly 
affecting kugel diameter (Figure 8B; p 0.0832). 
Because these data suggested Notch signalling was required for kugel formation, we 
examined expression of the Notch ligand dll4 in the double-transgenic reporter line 
Tg(dll4in3:eGFP), Tg(kdrl:HRAS-mCherry)s916. Upon visual examination no differential 
dll4 levels were observed in proximity to kugeln or kugel-parent-vessels (Figure 8C), 
suggesting that dll4 was not locally up- or down-regulated nearby kugeln. 
To further examine Notch signalling, we utilized the transgenic 
Tg(TP1bglob:VenusPest)s940, Tg(kdrl:HRAS-mCherry)s916. Expression of VenusPest 
is under the control of the synthetic Notch responsive element TP1 and was found to 
mainly be expressed in the midbrain and to a lesser extent in the hindbrain; but, again, 
no differential expression was seen adjacent to kugeln, in kugeln, or in kugel-parent-
vessels (Figure 8D). 
To determine which component of the Notch pathway is required for kugeln formation 
we examined the effect of morpholino knockdown of the Notch ligands dll4, notch1b, 
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jagged-1a and jagged-1b. Knockdown of dll4 or jagged-1b did not significantly affect 
kugel number or diameter (Figure EV4A,B,G,& H). However, morpholino knockdown 
of notch1b significantly reduced kugeln number (Figure EV4C; p 0.0008), without 
affecting diameter (Figure EV4D). Conversely, jagged-1a knockdown significantly 
increased kugel diameter (Figure EV4F; p 0.0097) without affecting kugeln number 
(Figure EV4E). 
 
Both inhibition and activation of Wnt signalling increase kugel number 
Since the dorsal central cranial vessels are dependent on Wnt signalling 20,40,41, the 
impact of Wnt signalling on kugeln formation was studied. Inhibition of Wnt signalling 
was achieved by application of XAV-939 42. This significantly increased number of 
kugeln per embryo (Figure 8E; p 0.0003), while not affecting kugel diameter (Figure 
8F; p 0.4098). 
Interestingly, activation of Wnt signalling by application of the GSK3 inhibitor XV which 
prevents ȕ-catenin phosphorylation 43 also significantly increased number of kugeln 
per embryo (Figure 8G; p<0.0001), while again not affecting kugel diameter (Figure 
8H). 
 
Discussion 
We here describe a previously unreported form of EC behaviour in zebrafish found 
only on the cerebral vessels. We believe that kugeln were not described previously 
due to their highly dynamic nature and low number per animal. Our discovery was 
greatly facilitated by state-of-the art light sheet microscopy that provided the required 
imaging speed and 3D imaging capability. Moreover, kugeln are only detectible in EC-
membrane-tagged reporter lines whereas many previous studies have utilised 
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cytoplasmic reporter lines that we have shown do not label kugeln. However, 
retrospective analysis of multiple datasets generated in Sheffield, Münster and 
Dresden confirmed their existence in unrelated zebrafish colonies, and they were 
detected using three different approaches to label endothelial membrane. This, 
coupled with their restriction to the cerebral vessels and their regulation by known 
biological pathways such as actin polymerisation as well as VEGF-, Notch-, and Wnt-
signalling confirms that kugeln formation is a real phenomenon. 
 
Kugeln are reliably observed from 3dpf onwards but are not present at 32hpf (2.3dpf). 
The reason for this timing of onset is not presently known and may relate to a waning 
of VEGF signalling (which would otherwise suppress kugeln formation), increasing 
Notch signalling in the brain, or a required state of maturity of the cerebral vessels. 
However, kugeln persist as late as 28dpf, so they do not represent a purely embryonic 
phenomenon. Unfortunately, the increasing size and opacity of zebrafish after 28dpf 
have prevented us from imaging older animals or adults. 
 
As well as representing the first description of kugeln, our manuscript has taken 
important steps towards understanding their biogenesis. Although kugel diameter 
greatly exceeds that of previously described vesicular membrane structures, kugel 
biogenesis shares common features with cellular blebs such as a requirement for actin 
polymerisation and Myosin II 13. Despite an appearance reminiscent of vascular 
aneurysms, unlike these kugeln are not multicellular and their formation appears not 
to be driven by blood flow. Because complete absence of blood flow throughout 
development prevents kugeln formation we speculate that some exposure to blood 
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flow may be needed to establish EC properties in the cerebral vessels such as polarity, 
shear stress responses and lumenisation 4,44, to allow kugeln to form. 
 
Although VEGF, Notch, and Wnt signalling have all been previously shown to play 
central roles in angiogenesis 17,19,20,27,38,45, they have not previously been implicated 
in vesicle biogenesis. We find that all three of these signalling pathways influence 
kugel formation. VEGF signalling inhibits, while Notch signalling is required for kugel 
formation. Our preliminary morpholino antisense studies suggested notch1b but not 
dll4 is required for kugel formation, and interestingly that perhaps jagged-1a may 
negatively regulate this. However, morpholinos are associated with a significant risk 
of off-target effects 46 and future studies using other approaches to induce loss-of-
function of these genes will be revealing. For example, an examination of kugel 
formation in stable mutants of these genes would be interesting although it may be 
challenging to discriminate between the effects of their loss-of-function on general 
cerebrovascular development. The recent establishment of endothelial specific 
CRISPR interference may also be informative 47. 
 
Our finding that the majority of kugeln contained high levels of NO was unexpected as 
NO is generally considered to passively diffuse from NO-producing cells and no NO-
containing organelle has previously been described 48. We speculate that 
accumulation of NO in kugeln may serve to establish a signalling or storage hub as 
described for secreted molecules such as Fgf3 49. This would provide a facility to 
deliver large amounts of NO rapidly. It is interesting that kugeln contain NO early in 
their lifetime, which, when coupled with their lack of cytoplasm, suggests that perhaps 
WKHLUIRUPDWLRQPLJKWEHUHODWHGWR³LQIODWLRQ´ZLWK12DOWKRXJKWKLVmight be expected 
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to be inhibited by L-NAME which we did not observe. Furthermore, most, but not all 
kugeln contain NO. It is possible therefore that regression of kugeln is associated with 
emptying of NO from the kugel, perhaps by diffusion into the tissue or lumen. 
The link between VEGF, NO and kugeln is unclear; VEGF induces NO release from 
ECs 31 but inhibits kugeln formation. It has been questioned whether zebrafish possess 
an orthologue of endothelial nitric oxide synthase (eNOS), but the balance of evidence 
suggests not 50. However, zebrafish do possess orthologues for inducible and 
neuronal NOS and it may be these isoforms that generated the NO we detected 51. 
 
Several key questions remain unanswered by our study. Why are kugeln restricted to 
the cerebral vessels and what is their function? We can presently only speculate, but 
the dependence of kugeln on Notch signalling may provide a clue. The brain is a site 
of marked Notch pathway activity to which the cerebral vessels are exposed, and this 
may explain the localisation of kugeln to these vessels. Several human genetic 
diseases affecting the cerebral vasculature are linked to the Notch pathway. For 
example, cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) is the most common monogenic form of ischaemic 
stroke and is caused by mutations in the Notch receptor NOTCH 52±54. Cerebral 
cavernous malformations (CCMs) are common large vascular cavernomas due to 
enlarged brain sinusoids. CCMs are caused by mutations in the CCM genes, which 
form a complex involved in stabilisation of endothelial junctions and VEGF signalling 
55,56
. Silencing CCM genes reduces Notch signalling, again implicating Notch 
dysregulation with human genetic cerebrovascular diseases. Since Notch inhibition 
impairs kugel formation, in addition to the fact that kugeln occurs in physiologically wild 
type (though transgenic) animals it seems most likely that kugel formation plays a 
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positive, though as yet unknown, function in maintaining cerebral vessels. To test this 
will require discovery of a method to specifically prevent kugel formation in order to 
test the effect on cerebrovascular function. 
 
It remains to be seen whether kugeln exist in mammals. Given the conservation of 
endothelial behaviour between zebrafish and mammals, we consider this highly likely. 
Although they have not previously been described, our findings show it is clear that 
kugeln are easy to overlook, particularly on histological examination of mammalian 
brains, which would easily mistake kugeln for capillaries. However, now that their 
existence is known, the use of membrane-tagged reporters or immunostaining, 
coupled with a marker of perfusion would be expected to reveal whether kugeln exist 
in the mammalian brain.  
We conclude that we have uncovered a striking subcellular phenomenon that appears 
restricted to cerebral vessels, emphasising that our understanding of the intricate 
processes during vascular development is far from complete. 
 
Material and Methods 
Zebrafish strains, handling and husbandry. Experiments performed at the 
University of Sheffield conformed to UK Home Office regulations and were performed 
under Home Office Project Licence 70/8588 held by TJAC. Experiments performed at 
the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden and the 
WWU Münster Institute for Cardiovascular Organogenesis and Regeneration 
conformed to guidelines of the relevant German animal ethics committees.  
Maintenance of adult zebrafish in all three fish facilities was conducted according to 
previously described husbandry standard protocols at 28°C with a 14:10 hours (h) 
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light:dark cycle 57. Embryos, obtained from controlled pair- or group-mating, were 
incubated in E3 buffer (5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4) with 
or without methylene blue.  
The following zebrafish lines were used; Tg(kdrl:HRAS-mCherry)s916 labels EC 
membrane 58 (AB background 59; Casper background 60), Tg(gata1:dsRed) labels red 
blood cells (RBCs) 61, Tg(fli1aep:CAAX-eGFP) labels EC membrane 22 (kindly 
provided by Holger Gerhardt), Tg(fli1a:eGFP)y1 labels EC cytoplasm 8, Tg(kdr:nls-
eGFP)zf109 labels EC nuclei 62, Tg(fli1a:Lifeact-mClover)sh467 labels endothelial 
filamentous actin47, and Tg(nbt:GCaMP3) labels neurons63, Tg(dll4in3:GFP) is 
expressed at sites of expression of the Notch delta-like ligand 4 45 (kindly provided by 
the De Val lab), Tg(TP1bglob:VenusPest)s940 labels arterial ECs 64. BLECs were 
studied in the double-transgenic lines Tg(kdrl:HRAS-mCherry)s916, 
Tg(flt4BAC:mCitrine)hu7135 65 and Tg(kdrl:HRAS-mCherry)s916, Tg(fli1a:Lifeact-
mClover)sh467. Macrophages were studied in Tg(fms:GAL4.VP16)i186, Tg(UAS-
E1b:nfsB.mCherry)il149, and Tg(kdrl:HRAS-mCherry)s916 66. Transient expression 
of Tg(fli1:myr-mCherry), labelling EC membrane 30,31, was achieved by injection of 
plasmid (50pg) with Tol2 RNA (75pg). 
Image acquisition. Datasets in Sheffield were obtained using a Zeiss Z.1 light sheet 
microscope with a water-dipping detection-objective (Plan-Apochromat 20x/1.0 Corr 
nd=1.38) and a scientific complementary metal-oxide semiconductor (sCMOS) 
detection unit. Data were acquired with activated pivot scan, dual-sided illumination 
and online fusion; properties of acquired data are as follows: 0.7x zoom, 16bit image 
depth, 1920x1920px image size and minimum z-stack interval (approx. 0.33 x 0.33x 
0.5µm). Green and red fluorophores were excited using 488nm and 561nm laser, 
respectively. Used filters in sequential tracks for multi-colour images were LP560 for 
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both and BP505-545 and LP585, respectively. Samples were embedded in 1% or 2% 
LMP-agarose containing 200 mg/l Tricaine (MS-222, Sigma). The image acquisition 
chamber was filled with E3 plus Tricaine (200mg/ml) and maintained at 28°C.  
Light sheet datasets in Dresden were obtained with a custom-built multidirectional 
SPIM (mSPIM) setup 67. The dorsum of the embryo head was imaged every 2.5min 
over 2 days with dual illumination and 3 µm z-spacing. The mSPIM setup was 
equipped with a Coherent Sapphire 561nm laser, two Zeiss 10x/0.2 illumination 
objectives, an UMPlanFL N Olympus 20x/0.5 NA detection objective and an Andor 
iXon 885 EM-CCD camera. To cover the cerebrovascular region, several regions were 
imaged and later stitched using custom image processing plugins in Fiji 68 based on 
the stitching tool from Stefan Preibisch 69. Samples were mounted in fluorinated 
propylene ethylene (FEP) tubes according to established mounting protocols 70. The 
FEP tubes were coated with 3% methyl cellulose and filled with 0.1% low-melting 
agarose containing 200 mg/l Tricaine to immobilize the zebrafish embryos during time-
lapse imaging. 
'DWDDFTXLVLWLRQIRUWKHVWXG\RI%/(&VZDVSHUIRUPHGDWWKH8QLYHUVLW\RI0ȨQVWHU
using a Leica SP8 microscope with a 40x water immersion objective (0.75x zoom) 
exciting with a 514 nm argon laser, 561 nm diode-pumped solid-state laser, 633 nm 
helium-neon and 514 / 561 / 633 beamsplitters. Properties of data acquired were as 
follows: 16bit image depth, 1024 x 1024px image size and 1µm minimum z-stack 
interval. Sample embedding was performed in 0.8% low-melting agarose with 200mg/l 
Tricaine. 
Microangiography. Vascular perfusion was visualized as previously described 71,72, 
using 20µg dextran tetramethylrhodamine (2,000,000 molecular weight, 
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ThermoFisher) at a concentration of 10mg/µL (2nl injection volume). 
Exsanguination and cessation of cardiac contraction. Exsanguination was 
achieved by mechanical opening of the heart with forceps. Temporary cessation of 
cardiac contraction was induced by treatment with 3.7mM Tricaine in E3. After 20min 
incubation and 30-40min image acquisition, samples were placed in E3 without 
Tricaine until full recovery of cardiac contraction to confirm non-lethality of Tricaine 
exposure. 
Morpholino antisense oligomer induced gene knockdown. Inhibition of induction 
of cardiac contraction was achieved by injection of an ATG blocking morpholino (MO) 
against cardiac troponin 2 (tnnt2a) at 1.58ng/embryo (Genetools, LLC; sequence 5'-
CATGTTTGCTCT GATCTGACACGCA-3') 25.  
Development of BLECs was inhibited by injection of an ATG blocking MO against 
collagen and calcium-binding EGF-like domain 1 (ccbe1) at 5ng/embryo (Genetools, 
LLC; sequence 5'-CGGGTAGATCATTTCAGACACTCTG-3') 73. 
The role of Notch signalling was investigated by injection of an ATG blocking MO 
against the following components: delta-like ligand 4 (dll4; 3ng; Genetools, LLC; 
VHTXHQFH ¶ - GAGAAAGGTGAGCCAAGCTGCCATG - ¶ 74, jagged-1a  (jag1a; 
0.1ng; 5'-GTCTGTCTGTGTGTCTGTCGCTGTG-3'; Genetools, LLC) 74, jagged-1b 
(jag1b; QJ*HQHWRROV//&VHTXHQFH¶- CTGAACTCCGTCGCAGAATCATGCC 
- ¶ 74, and notch 1b QJ *HQHWRROV //& VHTXHQFH ¶- 
GTTCCTCCGGTTACCTGGCATACAG - ¶75. 
 21 
Control MO injection was performed, according to the same protocol, with final 
concentrations as above (5'-CCTCTTACCTCAGTTATTTATA-3'; Genetools, LLC). All 
MO injections were conducted at one-cell-stage using phenol red as injection tracer. 
Tectum injections. Possible kugel scavenging activity was examined by injection of 
IgG-conjugated 150kDa Alexa Fluor 674 (0.2mg/ml, ThermoFischer) into the tectum 
and ventricle at 3dpf, as previously described 14. 
Chemical treatments. Actin polymerization was inhibited using 100nM Latrunculin B 
for 1h between 96-97hpf (Sigma-Aldrich) 76. 
Myosin II was inhibited using 25µM Blebbistatin (with 1% DMSO in end-solution for 
solubility) for 1h between 75-76hpf (Sigma) 77. 
VEGF signalling was inhibited using VEGF receptor inhibitor AV951 78 at 250nM for 
2h from 96-98hpf (Selleckchem; S1207; Tivozanib - AVEO pharmaceuticals). 
Notch signalling was inhibited using 50µM DAPT (Sigma-Aldrich) for 12h from 84-
96hpf 79.  
Wnt signalling was inhibited using 10µM XAV-939 for 4h from 72-76hpf (Sigma) 42. 
Wnt signalling activation was achieved by 10µM GSK-3 inhibitor XV for 4h from 72-
76hpf (Merck) 43. 
Control groups for the above experiments were performed using the same 
concentration and duration of DMSO in the active treatments. 
Inhibition of nitric oxide synthase (NOS) was achieved by 0.5mM L-NAME (Sigma-
Aldrich) dissolved in E3 for 18h from 3-4dpf 31. Controls were incubated in E3. 
The impact of osmotic pressure on kugeln was studied using 40mM glucose treatment 
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for 24h from 72-96hpf (Sigma). Controls were incubated in E3. 
The impact of cell membrane permeability on kugeln was studied by application of 
2.5% (v/v) DMSO for 24h from 72-96hpf (Sigma). Controls were incubated in E3. 
Vital dye staining. In vivo visualization of nitric oxide (NO) was performed using 
2.5µM DAF-FM-DA (Molecular Probes; D23844) 32 for 6h in 4dpf embryos (96-102hpf). 
DMSO control was performed at the same concentration and duration. To visualize 
acidic cellular compartments LysoTracker Green (Molecular Probes; L7526 DND-26) 
was applied for 5h (96-101hpf) at a concentration of 8.33µM in E3 35,36. Controls were 
incubated in E3. 
Image analysis and representation. Images were analysed using open-source 
software Fiji 68. Kymographs were produced via stack reslicing to study diameter 
changes of kugeln over time. To visualize data, maximum intensity projections (MIP) 
were generated and displayed using either grey (single channel) or red/green/blue 
(multi-channel) colour representations. Z-stack depth coding was conducted via 
hyper-stack time-coding. Intensity inversion was applied, as appropriate, to give the 
clearest rendering of relevant structures. Time-lapse data were displayed using MIPs. 
3D image reconstruction for 360-degree rotation was performed using Arivis software. 
Statistical analysis. All animals with sufficient image quality to be analysed were 
included. Animals were randomly allocated to treatment groups. Imaging and data 
analysis was performed unblinded to treatment allocation since the effects of treatment 
were usually obvious from the appearances of the micrographs. 
Normality of data was tested using D'Agostino-Pearson omnibus test. Statistical 
analysis of normally distributed data was performed using a One-way ANOVA to 
cRPSDUH PXOWLSOH JURXSV RU 6WXGHQW¶V W-test to compare two groups. Non-normally 
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distributed data were analysed with a Kruskal-Wallis test to compare multiple groups, 
or Mann-Whitney test to compare two groups. Diameter of kugeln is shown as average 
of all kugeln per embryo, unless otherwise indicated. Analysis was performed in 
GraphPad Prism Version 7 (GraphPad Software, La Jolla California USA). P values 
are indicated as follows: p<0.05 *, p<0.01 **, p<0.001 ***, p<0.0001 ****. Data 
represents mean and standard deviation (s.d.), if not otherwise stated. Image 
representation was performed using Inkscape (https://www.inkscape.org). 
 
Data Availability 
All data are available on request. 
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Figure Legends 
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Figure 1| Endothelial cells of the zebrafish embryonic cerebral vessels develop 
³NXJHOQ´; large spherical membrane protrusions. 
A MIP of cerebral vessels of 3dpf Tg(kdrl:HRAS-mCherry)s916 embryo (grey LUT; 
inverted). Higher magnification panel showing two kugeln (arrowheads) arising from 
the middle mesencephalic central artery (MMCtA).  
B Diameter of kugeln at 3dpf (mean ± s.e.m. 10.13 ± 0.49; n=93 kugeln from 32 3dpf 
embryos; 3 experimental repeats). 
C Number of kugeln per embryo in 3, 4 and 5dpf animals was not statistically 
significantly different (mean ± s.e.m. 3dpf 5.47 ± 1.09, 4dpf 7.47 ± 1.46, 5dpf 7.09 ± 
1.55; p = 0.8571; 3dpf: 175 kugeln from 32 embryos; 4dpf: 239 kugeln from 32 
embryos, 5dpf: 227 kugeln from 32 embryos; 4 experimental repeats; Kruskal-Wallis 
test). 
D Kugeln (arrowheads) could be observed in 28dpf animals. 
E MIP of cerebral vessels of 4dpf Tg(fli1aep:CAAX-eGFP) embryo (grey LUT; 
inverted). Higher magnification panel shows a kugel (arrowhead) protruding from the 
posterior mesencephalic central artery (PMCtA). 
F Single Z-plane micrograph of cerebral vessels of a 3dpf Tg(gata1:dsRed), injected 
with a Tol2-fli1a:myr-Cherry construct showing two kugeln (arrowheads) in the higher 
magnification panel protruding from the MMCtA. 
G Locations and proportion of kugeln on cerebral vessels (colour coded by vessel; 
total n=107 kugeln from 34 4dpf embryos; 3 experimental repeats). AMCtA ± anterior 
mesencephalic central artery, BCA ± basal communicating artery, CaDI ± caudal 
division of internal carotid artery, CMV ± communicating vessel, CtA ± central arteries, 
MMCtA ± middle mesencephalic central artery, MtA ± metencephalic artery, PCS ± 
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posterior communicating segment, PMBC ± posterior midbrain channel, PMCtA ± 
posterior mesencephalic central artery, PrA ± prosencephalic artery.   
H Location of kugeln by vessel and laterality (107 kugeln from 34 4dpf embryos; 3 
experimental repeats comparison of left vs right p 0.3592; Mann-Whitney U test). 
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Figure 2| Endothelial kugeln are transient and dynamically alter shape and size.  
A MIPs of a time-series light sheet acquisition shows three different kugeln (kugel 1 ± 
black arrowhead; kugel 2 ± grey arrowhead; kugel 3 ± unfilled arrowhead) protruding 
and retracting from parent vessels (2min intervals; inverted LUT). 
B Kugeln persisted for variable durations before regression into the parent vessel (43 
kugeln from 9 4dpf embyros; 4 experimental repeats).  
C MIPs taken 20min apart showing examples of different kugel behaviour including 
shape changes (asterisk), expansion (circle), retraction (triangle), or little change 
(pentagon).  
D MIPs taken 1h apart show that kugeln may be observed at one time-point (red 
arrowhead, 55:20:00) but not 1h later in the same animal (56:20:00) and to develop 
on other vessels 1h later (57:20:00) which again have regressed by 58:20:00. 
E Kymographs generated by line-scanning across the diameter of a typical kugel 
shows that kugel diameter oscillated with a periodicity of minutes, while no such 
oscillations were observed in adjacent similarly sized cerebral vessels (all images grey 
LUT; inverted). 
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Figure 3| Endothelial kugeln are non-nucleated with a filamenteous actin-
enriched neck.  
A Double transgenic visualizing endothelial membrane (red) and endothelial nuclei 
(green). Endothelial nuclei (arrowhead) were observed close to but never within the 
kugel (unfilled arrowhead).  
B Double transgenic showing endothelial membrane (red) and endothelial F-actin 
(green). F-actin was found to localize at the neck of the kugeln (arrowhead; see also: 
EV Movie3).  
C Double transgenic showing endothelial membrane (red) and endothelial cytoplasm 
(green). The cytoplasmic reporter was visible in the parent vessel but not in the kugel 
(unfilled arrowhead).  
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D Triple transgenic showing endothelial membrane (red), neurons (green) and 
erythrocytes (red). Surrounding neurons were excluded from the volume of the kugel 
(unfilled arrowhead) and erythrocytes were not observed inside kugeln (arrowhead).  
E Treatment with the inhibitor of actin polymerization Latrunculin B statistically 
significantly increased number of kugeln per embryo (100nM 1 hour; **p = 0.0041; 
control n=21 embryos 8.05 ± 1.76 (mean ± s.e.m.); Latrunculin n=21 embryos 17.19 ±  
2.93 (mean ± s.e.m.); 4dpf; 3 experimental repeats; Mann-Whitney U test).  
F Latrunculin B treatment statistically significantly reduced kugel diameter (*p = 
0.0164; control n=169 kugeln from 21 embryos 7.56 ± 2.25 (mean ± s.e.m.); 
Latrunculin n=361 kugeln from 21 embryos 5.91 ± 1.78 (mean ± s.e.m.); 4dpf; 3 
experimental repeats; 6WXGHQW¶V t-test).  
G Treatment with the Myosin II inhibitor Blebbistatin statistically significantly reduced 
number of kugeln per embryo (25 µM 1h; ****p <0.0001; control n=22 embryos 3.77 ±  
0.56 (mean ± s.e.m.), Blebbistatin n=24 embryos 1.08 ± 0.22 (mean ± s.e.m.); 3dpf; 3 
experimental repeats; Mann-Whitney U test). 
H Blebbistatin treatment had no effect on kugel diameter (p = 0.3731; control n=83 
kugeln from 22 embryos 6.27 ± 0.72 (mean ± s.e.m.), Blebbistatin n=26 kugeln from 
24 embryos 7.02 ± 0.89 (mean ± s.e.m.); 3dpf; 3 experimental repeats; Mann-Whitney 
U test). 
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Figure 4 | The relationship between endothelial kugeln and blood flow 
A MIP of the cerebral vessels of a 4dpf embryo before exsanguination (grey LUT; 
inverted). 
B MIP of the same embryo after exsanguination, which did not alter kugel size. 
C Time-lapse imaging of an embryo with transiently halted cardiac contraction (using 
Tricaine). Despite absent blood flow kugeln still changed shape (grey arrowhead), 
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retained shape (white arrowhead) or protruded and retracted (black arrowhead; time 
post cessation of flow is indicated on micrographs; 3dpf; grey inverted LUT). 
D Time-lapse of an embryo with transiently halted cardiac contraction as in (C) showed 
that kugel diameter still oscillates (time post cessation of flow).   
E Dextran microangiography filled perfused vessels with dextran (arrowhead), while 
dextran was not observed to enter kugeln (unfilled arrowhead). 
F Inhibition of cardiac contraction by tnnt2a morpholino (MO) knockdown statistically 
significantly reduced kugel number per embryo (****p<0.0001; control n=20 embryos 
5.10 ± 1.47 (mean ± s.e.m.), tnnt2a MO=18 embryos 0.06 ± 0.06 (mean ± s.e.m.); 
3dpf; 3 experimental repeats; Mann-Whitney U test). 
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Figure 5| Kugeln do not interact with brain lymphatic endothelial cells (BLECs) 
in Tg(fli1a:LifeAct-mClover)sh467, Tg(kdrl:HRAS-mCherry)s916, nor do they take 
up injected IgG-conjugated Alexa 674. 
A Kugeln were studied in the double-transgenic Tg(fli1a:LifeAct-mClover)sh467, 
Tg(kdrl:HRAS-mCherry)s916. 
B BLECs were mClover positive and mCherry-negative (BLECs - black arrowheads; 
kugeln ± white arrowheads).  
C No direct physical interaction between kugeln (BLECs - black arrowheads; kugeln ± 
white arrowheads) and BLECs was observed (n=21 4dpf embryos; 3 experimental 
repeats). 
D Depth-coded MIPs showed that BLECs and kugeln are present on different 
anatomical planes (depths; purple ventral (v), white dorsal (d); BLECs - black 
arrowheads; kugeln ± white arrowheads). 
E Ccbe1 morpholino (MO) injection led to a loss of lymphatics (white arrowhead). 
F Kugel number was not statistically significantly altered by ccbe1 morpholino (MO) 
knockdown (p = 0.3496; control MO n=22 embryos 0.95 ± 0.28 (mean ± s.e.m.), ccbe1 
MO n=23 embryos 0.57 ± 0.14 (mean ± s.e.m.); 3dpf; 3 experimental repeats; Mann-
Whitney U test). 
G Kugel diameter was not statistically significantly altered by ccbe1 MO knockdown (p 
= 0.8783; control MO n=21 kugeln from 22 embryos 7.75 ± 1.29 (mean ± s.e.m.), 
ccbe1 MO n=13 kugeln from 23 embryos 8.93 ± 2.35 (mean ± s.e.m.); 3dpf; 3 
experimental repeats; Mann-Whitney U test).  
H Injection of IgG-conjugated Alexa 647 into the tectum showed no uptake (blue; 
unfilled arrowhead) by kugeln (white arrowhead; 140 kugeln from 17 4dpf embryos; 2 
experimental repeats). 
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Figure 6| Kugeln do not interact with macrophages. 
A The possible interaction of macrophages with kugeln was studied in the transgenic 
Tg(kdrl:HRAS-mCherry)s916, Tg(fms:GAL4.VP16)i186, Tg(UAS-E1b:nfsB.mCherry)il149, 
visualizing macrophages and the vasculature simultaneously. 
B Coloured depth-coding indicates the different anatomical depths of kugeln and 
macrophages (ventral purple, dorsal white). 
C Maximum intensity projections of z-stacks acquired every 10 minutes during a time-
lapse showed no interaction of macrophages (unfilled arrowhead) with kugeln (filled 
arrowhead; n=21 kugeln in 8 3dpf embryos). Macrophages are all white, indicating 
they are on a different z-plane to the vessels seen. 
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Figure 7| Kugel number is increased by VEGF inhibition, and kugeln contain NO. 
A VEGF inhibition by 2h treatment with AV951 statistically significantly increased kugel 
number (****p<0.0001; DMSO control n=30 embryos 8.53 ± 2.62 (mean ± s.e.m.); 
 45 
AV951 n=31 embryos 21.10 ± 2.71 (mean ± s.e.m.); 4dpf; 4 experimental repeats; 
Mann-Whitney U test).  
B Mean kugel diameter was not statistically significantly different after AV951 
treatment (p = 0.7890; DMSO control n=243 kugeln from 30 embryos 9.94 ± 0.76 
(mean ± s.e.m.); AV951 n=652 kugeln from 31 embryos 9.73 ± 0.32 (mean ± s.e.m.); 
GSIH[SHULPHQWDOUHSHDWV6WXGHQW¶VW-test).   
C DAF-FM staining, a vital dye for nitric oxide (NO), showed that 57.56% of kugeln 
were positive for nitric oxide reactivity (2.5µM incubation from 96-102hpf; n=22 4dpf 
embryos; 118 of 205 kugeln filled; 3 experimental repeats). Images show 
UHSUHVHQWDWLYH³ILOOHG´'$)-)0SRVLWLYHDQG³XQILOOHG´'$)-FM negative) kugeln.  
D Time-lapse acquisition with DAF-FM revealed that kugeln contained NO early in 
their biogenesis (grey LUT; inverted). 
E Application of LysoTracker, a vital dye that stains lysosomes or acidic 
compartments, showed that 17.08% of kugeln contained acidic contents (8.33µM; 96-
101hpf; n=22 4dpf embryos; 62 of 363 kugeln filled; 3 experimental repeats). Images 
VKRZUHSUHVHQWDWLYH³ILOOHG´/\VRWUDFNHUSRVLWLYHDQG³XQILOOHG´/\VRWUDFNHUQHJDWLYH
kugeln. 
F The nitric oxide synthase (NOS) inhibitor L-NAME had no statistically significant 
effect on kugel number per embryo (0.5mM L-NAME 18h; p = 0.4870; control n=22 
embryos 14.27 ± 3.35 (mean ± s.e.m.), L-NAME n=24 embryos 7.46 ± 1.61 (mean ± 
s.e.m.); 4dpf; 3 experimental repeats; Mann-Whitney U test). 
G Diameter of kugeln was not affected by L-NAME (p = 0.4161; control n=315 kugeln 
from 22 embryos 8.77 ± 0.49 (mean ± s.e.m.), L-NAME n=179 kugeln from 24 8.66 ± 
0.71 (mean ± s.e.m.); 4dpf; 3 experimental repeats; Mann-Whitney U test). 
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Figure 8| Kugel number is decreased by Notch inhibition but increased by Wnt 
inhibition or activation. 
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A Kugel number was significantly decreased by inhibition of Notch signalling by 12h 
treatment with 50µM DAPT (****p<0.0001; control n=24 embryos 9.38 ± 1.77 (mean ± 
s.e.m.), DAPT n=24 embryos 0.92 ± 0.28 (mean ± s.e.m.); 4dpf; 3 experimental 
repeats; Mann-Whitney U test).  
B Mean kugel diameter was not statistically significantly altered by DAPT treatment (p 
= 0.0832; control n=225 kugeln from 24 embryos 8.64 ± 0.54 (mean ± s.e.m.); DAPT 
n=22 kugeln from 24 embryos 6.88 ± 0.86 (mean ± s.e.m.); 4dpf; 3 experimental 
UHSHDWV6WXGHQW¶VW-test). 
C A transgenic dll4 reporter line showed no indication of different dll4 expression at 
the sites of kugeln (white arrowheads pointing to kugeln; n=122 kugeln from 23 3dpf 
embryos; 2 experimental repeats). 
D Studying Notch signalling in the Notch reporter line Tg(TP1glob:venusPest)s940, 
showed high Notch levels in the mid-brain, but, again, no difference in expression at 
the sites of kugeln (n=45 kugeln from 19 4dpf embryos; 2 experimental repeats). 
E Kugel number was statistically significantly increased by inhibition of Wnt signalling 
by 4h treatment with 10µm XAV-939 (***p = 0.0003; control n=22 embryos 1.32 ± 0.24 
(mean ± s.e.m.); XAV-939 n=21 embryos 4.29 ± 0.71 (mean ± s.e.m.); 3dpf; 3 
experimental repeats; Mann-Whitney U test). 
F Kugel diameter was not statistically significantly altered by XAV-939 (p = 0.4098; 
control n=29 kugeln from 22 embryos 8.78 ± 0.76 (mean ± s.e.m.); XAV-939 n=90 
kugeln from 21 embryos 7.99 ± 0.56 (mean ± s.e.m.); 3dpf; 3 experimental repeats; 
6WXGHQW¶VW-test) 
G Kugel number was statistically significantly increased by activation of Wnt signalling 
by 4h treatment with 10µm GSK3 inhibition XV (p 0.0359; control n=22 embryos 1.04 
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± 0.34 (mean ± s.e.m.); GSK3 inhibitor n=21 embryos 4.24 ± 1.28 (mean ± s.e.m.); 
3dpf; 3 experimental repeats; Mann-Whitney U test). 
H The diameter of kugel was not statistically significantly altered by GSK3 inhibition (p 
0.5555; control n=23 kugeln from 22 embryos 7.26 ± 0.89 (mean ± s.e.m.); GSK3 
inhibitor n=89 kugeln from 21 embryos 8.09 ± 0.97 (mean ± s.e.m.); 3dpf; 3 
H[SHULPHQWDOUHSHDWV6WXGHQW¶VW-test). 
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Expanded View Figure Legends 
 
Figure EV1| Kugeln were observed in the transgenic Tg(fli1aep:eGFP-CAAX). 
A MIP of cerebral vessels of 4dpf Tg(fli1aep:eGFP-CAAX) embryo. 
B Time-lapse acquisitions showed that kugeln were dynamic (black arrowhead) as in 
Tg(kdrl:HRAS-mCherry)s916, showing protrusion, shape changes, oscillation and 
retraction. 
C Additional time-lapse acquisitions in the Tg(fli1a:myr-mCherry), Tg(gata1:dsRed) 
showed equally dynamics of kugeln (black arrowhead; images grey LUT; inverted). 
 
Figure EV 2| Kugeln number or diameter are not altered by changes of 
membrane permeability or osmotic pressure. 
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A The influence of membrane permeability increase was studied by application of 
DMSO; the number of kugeln was not statistically significantly changed (2.5% DMSO 
24h; p = 0.1596; control n=25 embryos 4.00 ± 0.65 (mean ± s.e.m.), DMSO n=25 
embryos 3.00 ± 0.62 (mean ± s.e.m.); 4dpf; 3 experimental repeats; Mann-Whitney U 
test). 
B Diameter of kugeln was not statistically significantly different after incubation with 
DMSO (p = 0.3665; control n=97 kugeln from 25 embryos 8.68 ± 0.71 (mean ± s.e.m.), 
DMSO n=75 kugeln from 25 9.76 ± 0.67 (mean ± s.e.m.); 4dpf; 3 experimental repeats; 
6WXGHQW¶V t-test). 
C The impact of osmotic pressure on kugeln was studied by application of glucose; no 
statistically significant difference was observed (40mM glucose 24h; p = 0.7371; 
control n=22 embryos 2.46 ±  0.36 (mean ± s.e.m.), glucose n=21 embryos 3.24 ± 
0.65 (mean ± s.e.m.); 4dpf; 2 experimental repeats; Mann-Whitney U test). 
D Kugel diameter was not statistically significantly different after incubation with 
glucose (p = 0.7060; control n=54 kugeln from 22 embryos 10.09 ± 1.02 (mean ± 
s.e.m.), glucose n=67 kugeln from 21 embryos 10.66 ± 4.65 (mean ± s.e.m.); 4dpf; 2 
experimental repeats; 6WXGHQW¶V t-test). 
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Figure EV 3| Kugeln do not interact with BLECs in Tg(flt4BAC:mCitrine)hu7135, 
Tg(kdrl:HRAS-mCherry)s916. 
A Kugeln (white arrowhead) were additionally studied in the transgenic 
Tg(flt4BAC:mCitrine)hu7135, Tg(kdrl:HRAS-mCherry)s916, which was more specific for 
BLECs, using confocal microscopy to allow higher resolution imaging. 
B Ccbe1 morpholino (MO) injection lead to loss of BLECs, while kugeln were still 
observed (white arrowhead). 
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C The number of kugeln was not statistically significantly altered by ccbe1 morpholino 
(MO) knockdown (p = 0.1472; control n=17 embryos 1.65 ± 0.58 (mean ± s.e.m.), 
ccbe1 MO n=17 embryos 4.77 ± 1.85 (mean ± s.e.m.); 4dpf; 2 experimental repeats; 
Mann-Whitney U test). 
D Diameter of kugeln was not statistically significantly altered upon ccbe1 MO injection 
(p = 0.0962; control n=27 kugeln from 17 embryos 7.22 ± 1.17 (mean ± s.e.m.), ccbe1 
MO n=81 kugeln from 17 embryos 5.12 ± 0.60 (mean ± s.e.m.); 2 experimental 
repeats; 6WXGHQW¶V t-test). 
E Injection of IgG-conjugated Alexa 647 into the tectum (open arrowhead) showed no 
uptake of IgG-conjugated Alexa 647 by kugeln (n=52 kugeln from 5 5dpf embryos, 
kugeln indicated by white arrowheads). 
 
 53 
Figure EV 4| The effect of morpholino knockdown of dll4, notch1b, jagged-1a 
and jagged-1b on kugeln number and diameter. 
A Number of kugeln per embryo was not statistically significantly changed upon dll4 
MO injection (p = 0.9639; control n=23 embryos 1.30 ± 0.22 (mean ± s.e.m.), dll4 MO 
n=23 embryos 1.96 ± 0.52 (mean ± s.e.m.); 3dpf; 3 experimental repeats; Mann-
Whitney U test). 
B Kugel diameter was not statistically significantly changed upon dll4 MO injection (p 
= 0.0843; control n=30 kugeln from 23 embryos 6.13 ± 0.94 (mean ± s.e.m.), dll4 MO 
n=45 kugeln from 23 embryos 8.35 ± 1.15 (mean ± s.e.m.); 3dpf; 3 experimental 
repeats; Mann-Whitney U test). 
C Number of kugeln was statistically significantly reduced after notch1b MO injection 
(***p = 0.0008; control n=23 embryos 1.52 ± 0.27 (mean ± s.e.m.), notch1b MO n=23 
embryos 0.39 ± 0.14 (mean ± s.e.m.); 3dpf; 3 experimental repeats; Mann-Whitney U 
test). 
D Kugel diameter was not statistically significantly changed upon notch1b MO injection 
(p = 0.3198; control n=37 kugeln from 23 embryos 7.93 ±  1.07 (mean ± s.e.m.), 
notch1b MO n=9 kugeln from 23 embryos 5.61 ± 0.79 (mean ± s.e.m.); 3 experimental 
repeats; Mann-Whitney U test). 
E Number of kugeln was not statistically significantly changed after jagged-1a MO 
injection (p = 0.9563; control n=11 embryos 2.36 ± 0.41 (mean ± s.e.m.), jagged-1a 
MO n=9 embryos 2.33 ± 0.33 (mean ± s.e.m.)GSIH[SHULPHQWDOUHSHDWV6WXGHQW¶V
t-test). 
F Kugel diameter was found to be statistically significantly changed upon jagged-1a 
MO injection (**p = 0.0097; control n=23 kugeln from 11 embryos 7.89 ± 0.94 (mean 
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± s.e.m.), jagged-1a MO n=20 kugeln from 9 embryos 11.58 ± 0.97 (mean ± s.e.m.); 
3dpf; 2 experimental repeats; Mann-Whitney U test). 
G Number of kugeln per embryo was not statistically significantly changed upon 
jagged-1b MO injection (p = 0.3042; control n=21 embryos 1.76 ± 0.25 (mean ± 
s.e.m.), jagged-1b MO n=21 embryos 1.48 ± 0.34 (mean ± s.e.m.); 3dpf; 3 
experimental repeats; Mann-Whitney U test). 
H Kugel diameter was not statistically significantly changed upon jagged-1b MO 
injection (p = 0.7060; control n=19 kugeln from 21 embryos 5.88 ± 0.65 (mean ± 
s.e.m.), jagged-1b MO n=14 kugeln from 21 embryos 6.53 ± 0.76 (mean ± s.e.m.); 
3dpf; 3 experimental repeats; Mann-Whitney U test). 
 
